Geoffrey Buckle, MD, MPH
Assistant Professor
Medicine
School of Medicine

Buckle's research focuses on improving outcomes for people with cancer in underserved settings, with a particular focus on the growing cancer burden in sub-Saharan Africa. He studies region-specific risk factors for cancer and is working on developing ways to improve early cancer detection.

Buckle earned his medical degree at the University of Massachusetts Medical School. He completed a residency in internal medicine and a fellowship in medical oncology at UCSF. He also completed a master of public health degree at the Johns Hopkins Bloomberg School of Public Health.

Buckle is a member of the UCSF Global Cancer Program, American Society of Clinical Oncology and African Organisation for Research and Training in Cancer. In 2022, he received a Global Oncology Young Investigator Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology.

• A roadmap to establishing global oncology as a priority initiative within a National Cancer Institute-designated cancer center.
  Journal of the National Cancer Institute 2024 Van Loon K, Breithaupt L, Ng D, DeBoer RJ, Buckle GC, Bialous S, Hiatt RA, Volberding P, Hermiston ML, Ashworth A
• Human Papillomavirus-Associated Head and Neck Malignancies in Sub-Saharan Africa: A Systematic Review.
  JCO global oncology 2023 Okerosi S, Mokoh LW, Rubagumya F, Niyibizi BA, Nkya A, Van Loon K, Buckle G, Bent S, Ha P, Fagan JJ, Ng D, Aswani J, Xu MJ
• An international report on bacterial communities in esophageal squamous cell carcinoma.
  International journal of cancer 2022 Nomburg J, Bullman S, Nasrollahzadeh D, Collisson EA, Abedi-Ardekani B, Akoko LO, Atkins JR, Buckle GC, Gopal S, Hu N, Kaimila B, Khoshnia M, Malekzadeh R, Menya D, Mmbaga BT, Moody S, Mulima G, Mushi…
• Risk Factors Associated With Early-Onset Esophageal Cancer in Tanzania.
  JCO global oncology 2022 Buckle GC, Mmbaga EJ, Paciorek A, Akoko L, Deardorff K, Mgisha W, Mushi BP, Mwaiselage J, Hiatt RA, Zhang L, Van Loon K
• Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study.
  BMC cancer 2022 Buckle GC, Mrema A, Mwachiro M, Ringo Y, Selekwa M, Mulima G, Some FF, Mmbaga BT, Mody GN, Zhang L, Paciorek A, Akoko L, Ayuo P, Burgert S, Bukusi E, Charles A, Chepkemoi W, Chesumbai G, Kaimila B, …
• Views from Multidisciplinary Oncology Clinicians on Strengthening Cancer Care Delivery Systems in Tanzania.
  The oncologist 2021 Nyagabona SK, Luhar R, Ndumbalo J, Mvungi N, Ngoma M, Meena S, Siu S, Said M, Mwaiselage J, Tarimo E, Buckle G, Selekwa M, Mushi B, Mmbaga EJ, Van Loon K, DeBoer RJ
• Improving Access to Self-Expanding Metal Stents for Patients With Esophageal Cancer in Eastern Africa: A Stepwise Implementation Strategy.
  JCO global oncology 2021 Mushi BP, Mwachiro MM, Buckle G, Kaimila BN, Mulima G, Kayamba V, Kelly P, Akoko L, Mmbaga EJ, Selekwa M, Ringo Y, Pritchett N, White RE, Topazian MD, Fleischer DE, Dawsey SM, Van Loon K
• A Case-Control Study to Evaluate Environmental and Lifestyle Risk Factors for Esophageal Cancer in Tanzania.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 Mmbaga EJ, Mushi BP, Deardorff K, Mgisha W, Akoko LO, Paciorek A, Hiatt RA, Buckle GC, Mwaiselage J, Zhang L, Van Loon K
• The global burden of disease study 2013: What does it mean for the NTDs?
  PLoS neglected tropical diseases 2017 Herricks JR, Hotez PJ, Wanga V, Coffeng LE, Haagsma JA, Basáñez MG, Buckle G, Budke CM, Carabin H, Fèvre EM, Fürst T, Halasa YA, King CH, Murdoch ME, Ramaiah KD, Shepard DS, Stolk WA, Undurraga EA, …
• Burden of diarrhea in the Eastern Mediterranean Region, 1990-2015: Findings from the Global Burden of Disease study
  Int J Public Health 2017 GBD 2015 Eastern Mediterranean Region Diarrhea Collaborators
• Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.
  Lancet (London, England) 2015 GBD 2013 DALYs and HALE Collaborators, Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, Aboyans V, Abraham JP, Abubakar I, Abu-Raddad LJ, Abu-Rmeileh NM, Achoki T, …
• Hospital detention practices: statement of a global taskforce.
  Lancet (London, England) 2015 Mostert S, Lam CG, Njuguna F, Patenaude AF, Kulkarni K, Salaverria C, SIOP PODC Global Taskforce on Hospital Detention Practices
• Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
  Lancet (London, England) 2015 Global Burden of Disease Study 2013 Collaborators
• Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
  Lancet (London, England) 2014 GBD 2013 Mortality and Causes of Death Collaborators
• Blood and Lymphatic Cancer: Targets and Therapy
  Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources 2014 Moormann AM, Skiles J, Otieno J, Buckle GC and Vik TA
• The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases.
  PLoS neglected tropical diseases 2014 Hotez PJ, Alvarado M, Basáñez MG, Bolliger I, Bourne R, Boussinesq M, Brooker SJ, Brown AS, Buckle G, Budke CM, Carabin H, Coffeng LE, Fèvre EM, Fürst T, Halasa YA, Jasrasaria R, Johns NE, Keiser J, …
• Long-term follow-up of a phase II trial of chemotherapy plus hormone therapy for biochemical relapse after definitive local therapy for prostate cancer.
  Urology 2013 Nakabayashi M, Xie W, Buckle G, Bubley G, Ernstoff MS, Walsh W, Morganstern DE, Kantoff PW, Taplin ME
• The Lancet
  GBD 2010 Country Results: a Global Public Good 2013 GBD 2010 Country Collaboration
• Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
  Lancet (London, England) 2012 Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, …
• Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
  Lancet (London, England) 2012 Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, …
• Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer.
  BJU international 2012 Nakabayashi M, Werner L, Courtney KD, Buckle G, Oh WK, Bubley GJ, Hayes JH, Weckstein D, Elfiky A, Sims DM, Kantoff PW, Taplin ME
• Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010.
  Journal of global health 2012 Buckle GC, Walker CL, Black RE
• Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Choueiri TK, Ross RW, Jacobus S, Vaishampayan U, Yu EY, Quinn DI, Hahn NM, Hutson TE, Sonpavde G, Morrissey SC, Buckle GC, Kim WY, Petrylak DP, Ryan CW, Eisenberger MA, Mortazavi A, Bubley GJ, Taplin …
• Assessment of liver disease (noninvasive methods).
  Current opinion in HIV and AIDS 2011 Mehta SH, Buckle GC